These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 4101579

  • 41. Coagulation disorders in cancer. I. Clinical and laboratory studies.
    Miller SP, Sanchez-Avalos J, Stefanski T, Zuckerman L.
    Cancer; 1967 Sep; 20(9):1452-65. PubMed ID: 6038391
    [No Abstract] [Full Text] [Related]

  • 42. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys].
    Furlan M, Leupin L, Biasiutti FD, Lämmle B.
    Schweiz Med Wochenschr; 1991 Jul 20; 121(29):1068-71. PubMed ID: 1891701
    [Abstract] [Full Text] [Related]

  • 43. Two different fibrinogen gene mutations associated with bleeding in the same family (A αGly13Glu and γGly16Ser) and their impact on fibrin clot properties: fibrinogen Krakow II and Krakow III.
    Pietrys D, Balwierz W, Iwaniec T, Vorjohann S, Neerman-Arbez M, Undas A.
    Thromb Haemost; 2011 Sep 20; 106(3):558-60. PubMed ID: 21725578
    [No Abstract] [Full Text] [Related]

  • 44. The occurrence and significance of fibrin-fibrinogen degradation products (FDP) in acute infections.
    Skånsberg P, Cronberg S, Nilsson IM.
    Scand J Infect Dis; 1974 Sep 20; 6(2):197-203. PubMed ID: 4854978
    [No Abstract] [Full Text] [Related]

  • 45. Coagulation disorders in cancer. II. Multiple myeloma.
    Sanchez-Avalos J, Soong BC, Miller SP.
    Cancer; 1969 Jun 20; 23(6):1388-98. PubMed ID: 5771067
    [No Abstract] [Full Text] [Related]

  • 46. Methods for differential diagnosis of consumption coagulopathy.
    Maki M, Sasaki K, Sato S.
    Tohoku J Exp Med; 1969 Dec 20; 99(4):347-60. PubMed ID: 4984387
    [No Abstract] [Full Text] [Related]

  • 47. Hereditary dysfibrinogenemia.
    Bithell TC.
    Clin Chem; 1985 Apr 20; 31(4):509-16. PubMed ID: 3978780
    [Abstract] [Full Text] [Related]

  • 48. Developments in transient hemorrhagic disorders.
    Rowe AJ, Leveson JE.
    Tex Med; 1973 Feb 20; 69(2):72-8. PubMed ID: 4569430
    [No Abstract] [Full Text] [Related]

  • 49. [Differential diagnosis between primary and secondary hyperfibrinolysis].
    Heene DL.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970 Feb 20; 94(2):186-94. PubMed ID: 4098772
    [No Abstract] [Full Text] [Related]

  • 50. [STUDIES ON THE THROMBIN TEST IN LIVER AND BILIARY TRACT DISEASES].
    SONODA N.
    Iryo; 1964 Jul 20; 18():439-44. PubMed ID: 14196266
    [No Abstract] [Full Text] [Related]

  • 51. Congenital deficiency of factor 13 (fibrin-stabilizing factor): Report of a case and review of the literature.
    Britten AF.
    Am J Med; 1967 Nov 20; 43(5):751-61. PubMed ID: 6054840
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
    Lane DA, Southan C, Ireland H, Thompson E, Kehl M, Henschen A.
    Br J Haematol; 1983 Apr 20; 53(4):587-97. PubMed ID: 6830702
    [Abstract] [Full Text] [Related]

  • 55. A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
    Thomas DP, Niewiarowski S, Myers AR, Bloch KJ, Colman RW.
    N Engl J Med; 1970 Sep 24; 283(13):663-8. PubMed ID: 4247823
    [No Abstract] [Full Text] [Related]

  • 56. Preferential degradation of soluble fibrin monomers in streptokinase-activated plasma.
    Konttinen YP, Lalla ML, Turunen O.
    Thromb Diath Haemorrh; 1973 Nov 24; 30(2):403-13. PubMed ID: 4543990
    [No Abstract] [Full Text] [Related]

  • 57. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M, Feijge MA, Baaten CC, Kuiper GJ, Marcus MA, Ten Cate H, Lancé MD, Heemskerk JW, van der Meijden PE.
    Thromb Haemost; 2014 Mar 03; 111(3):447-57. PubMed ID: 24258426
    [Abstract] [Full Text] [Related]

  • 58. Clotting factors and fibrinogen split products in the extravasular space.
    Benz JJ.
    Thromb Diath Haemorrh; 1968 Mar 31; 19(1):226-35. PubMed ID: 5652229
    [No Abstract] [Full Text] [Related]

  • 59. The original haemorrhagic fever: yellow fever.
    Dennis LH, Reisberg BE, Crosbie J, Crozier D, Conrad ME.
    Br J Haematol; 1969 Nov 31; 17(5):455-62. PubMed ID: 4981419
    [No Abstract] [Full Text] [Related]

  • 60. [Blood coagulation and excretion of coagulation and fibrinolysis factors with urine of patients with diffuse glomerulonephritis].
    Zorina SS, Krasik IaD.
    Ter Arkh; 1974 Nov 31; 46(7):54-62. PubMed ID: 4408677
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.